Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Feb;142(2):541–546.

Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.

O W Kamel 1, A B Gelb 1, R B Shibuya 1, R A Warnke 1
PMCID: PMC1886744  PMID: 7679553

Abstract

Several recent reports have suggested that nodular lymphocyte predominance Hodgkin's disease (NLPHD) may be distinct from other forms of Hodgkin's disease and may be more closely related to B-cell non-Hodgkin's lymphoma. This is primarily based on immunophenotypic studies that have shown that the L & H cells in NLPHD demonstrate a B-cell phenotype. In 1989, Poppema reported that the T cells in NLPHD differ from T cells in other forms of Hodgkin's disease in that they demonstrate reactivity for Leu 7 (CD57). In this study we tested the hypothesis that Leu 7 (CD57) reactivity of small lymphocytes in NLPHD is an immunophenotypic feature that distinguishes NLPHD from nodular sclerosing Hodgkin's disease and from certain B-cell lymphomas that may histologically simulate NLPHD, namely T-cell-rich B-cell lymphoma and follicular lymphoma. Using an image analysis method, we found Leu 7 (CD57) reactivity in an average of 18.9% of the small lymphocytes in the nodules of NLPHD compared with 3.9% in nodular sclerosing Hodgkin's disease, 4.3% in T-cell-rich B-cell lymphoma, and 2.1% in follicular lymphoma. Moreover, Leu 7 (CD57)-reactive small lymphocytes often showed a distinctive pattern in NLPHD, forming a ring of cells around the large L & H cells. While scattered Leu 7 (CD57)-reactive lymphocytes were found in the other disorders, the percentage of reactive cells and the pattern of reactivity were significantly different in NLPHD. These results suggest that Leu 7 (CD57) reactivity may be used as an additional immunophenotypic criterion in distinguishing NLPHD from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma, and follicular lymphoma. The clinical and biological significance of Leu 7 (CD57) reactivity of small lymphocytes in NLPHD merits further investigation.

Full text

PDF
541

Images in this article

543Figure 1
on p.543
543Figure 2
on p.543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Abo T., Cooper M. D., Balch C. M. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol. 1982 Oct;129(4):1752–1757. [PubMed] [Google Scholar]
  3. Abo T., Miller C. A., Gartland G. L., Balch C. M. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med. 1983 Jan 1;157(1):273–284. doi: 10.1084/jem.157.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bailar J. C., 3rd Science, statistics, and deception. Ann Intern Med. 1986 Feb;104(2):259–260. doi: 10.7326/0003-4819-104-2-259. [DOI] [PubMed] [Google Scholar]
  5. Banerjee D., Baril J., Bell D. A., McFarlane D., Karim R. Suppression of immunoglobulin production by germinal centre HNK-1+ CD3+ cells. Adv Exp Med Biol. 1988;237:421–425. doi: 10.1007/978-1-4684-5535-9_64. [DOI] [PubMed] [Google Scholar]
  6. Chittal S. M., Alard C., Rossi J. F., al Saati T., Le Tourneau A., Diebold J., Delsol G. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol. 1990 Nov;14(11):1024–1035. doi: 10.1097/00000478-199011000-00004. [DOI] [PubMed] [Google Scholar]
  7. Ghali V. S., Jimenez E. J., Garcia R. L. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol. 1992 Jan;23(1):21–25. doi: 10.1016/0046-8177(92)90005-n. [DOI] [PubMed] [Google Scholar]
  8. Hansmann M. L., Stein H., Fellbaum C., Hui P. K., Parwaresch M. R., Lennert K. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989 Dec;20(12):1169–1175. doi: 10.1016/s0046-8177(89)80007-3. [DOI] [PubMed] [Google Scholar]
  9. Johnson M. D., Glick A. D., Davis B. W. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas. Arch Pathol Lab Med. 1988 Feb;112(2):155–160. [PubMed] [Google Scholar]
  10. Kamel O. W., LeBrun D. P., Davis R. E., Berry G. J., Warnke R. A. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol. 1991 Jun;138(6):1471–1477. [PMC free article] [PubMed] [Google Scholar]
  11. Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
  12. LeBrun D. P., Kamel O. W., Dorfman R. F., Warnke R. A. Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody specific for immunoglobulin M. Am J Clin Pathol. 1992 Jan;97(1):135–138. doi: 10.1093/ajcp/97.1.135. [DOI] [PubMed] [Google Scholar]
  13. Miettinen M., Franssila K. O., Saxén E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer. 1983 Jun 15;51(12):2293–2300. doi: 10.1002/1097-0142(19830615)51:12<2293::aid-cncr2820511221>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  14. Nicholas D. S., Harris S., Wright D. H. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study. Histopathology. 1990 Feb;16(2):157–165. doi: 10.1111/j.1365-2559.1990.tb01084.x. [DOI] [PubMed] [Google Scholar]
  15. Osborne B. M., Butler J. J., Pugh W. C. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol. 1990 Oct;14(10):933–938. doi: 10.1097/00000478-199010000-00006. [DOI] [PubMed] [Google Scholar]
  16. Pinkus G. S., Said J. W. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol. 1988 Nov;133(2):211–217. [PMC free article] [PubMed] [Google Scholar]
  17. Poppema S. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol. 1989 Aug;135(2):351–357. [PMC free article] [PubMed] [Google Scholar]
  18. Poppema S., Timens W., Visser L. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma. Adv Exp Med Biol. 1985;186:963–969. doi: 10.1007/978-1-4613-2463-8_116. [DOI] [PubMed] [Google Scholar]
  19. Poppema S., Visser L., De Leij L. Reactivity of presumed anti-natural killer cell antibody Leu 7 with intrafollicular T lymphocytes. Clin Exp Immunol. 1983 Dec;54(3):834–837. [PMC free article] [PubMed] [Google Scholar]
  20. Ramsay A. D., Smith W. J., Isaacson P. G. T-cell-rich B-cell lymphoma. Am J Surg Pathol. 1988 Jun;12(6):433–443. doi: 10.1097/00000478-198806000-00003. [DOI] [PubMed] [Google Scholar]
  21. Scarpa A., Bonetti F., Zamboni G., Menestrina F., Chilosi M. T-cell-rich B-cell lymphoma. Am J Surg Pathol. 1989 Apr;13(4):335–337. doi: 10.1097/00000478-198904000-00010. [DOI] [PubMed] [Google Scholar]
  22. Stein H., Hansmann M. L., Lennert K., Brandtzaeg P., Gatter K. C., Mason D. Y. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol. 1986 Sep;86(3):292–297. doi: 10.1093/ajcp/86.3.292. [DOI] [PubMed] [Google Scholar]
  23. Sundeen J. T., Cossman J., Jaffe E. S. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? Am J Surg Pathol. 1988 Aug;12(8):599–606. [PubMed] [Google Scholar]
  24. Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest. 1986 Apr;54(4):457–461. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES